ArrowMark Colorado Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

ArrowMark Colorado Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200,300	Closed	-$853K	–	339
2022 Q1	$853K	Sell	200,300 -298,217	-60%	-$1.64M	0.01%	295
2021 Q4	$4.67M	Sell	498,517 -111,677	-18%	-$2.31M	0.04%	247
2021 Q3	$16.8M	Buy	610,194 +317,871	+109%	+$8.58M	0.13%	140
2021 Q2	$8.18M	Buy	292,323 +45,152	+18%	+$1.28M	0.06%	222
2021 Q1	$8.2M	Sell	247,171 -6,183	-2%	-$265K	0.06%	211
2020 Q4	$12.2M	Buy	+253,354	New	+$11.9M	0.09%	157

Other funds holding OLMA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ArrowMark Colorado Holdings's OLMA Position: Q2 2022 in Review

ArrowMark Colorado Holdings sold out of Olema Pharmaceuticals (OLMA) in Q2 2022, closing a stake of 200,300 shares — an estimated $853K sold.

ArrowMark Colorado Holdings first reported a position in OLMA in Q4 2020 and held it in 6 quarters. The position peaked at $16.8M in Q3 2021. 76 funds tracked by Wall St. Rank hold OLMA as of Q2 2022.

ArrowMark Colorado Holdings reported no remaining Olema Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
ArrowMark Colorado Holdings sold 200,300 Olema Pharmaceuticals shares in Q2 2022, an estimated $853K.
ArrowMark Colorado Holdings first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 6 quarters.
ArrowMark Colorado Holdings's Olema Pharmaceuticals position peaked at $16.8M in Q3 2021.
76 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2022.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.